Pantelis Sarafidis
Cited by
Cited by
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondaryá…
GL Bakris, PA Sarafidis, MR Weir, B Dahl÷f, B Pitt, K Jamerson, ...
The Lancet 375 (9721), 1173-1181, 2010
Resistant hypertension: an overview of evaluation and treatment
PA Sarafidis, GL Bakris
Journal of the American College of Cardiology 52 (22), 1749-1757, 2008
Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome
G Bakris, M Molitch, A Hewkin, M Kipnes, P Sarafidis, K Fakouhi, ...
Diabetes care 29 (12), 2592-2597, 2006
Hypertension awareness, treatment, and control in chronic kidney disease
PA Sarafidis, S Li, SC Chen, AJ Collins, WW Brown, MJ Klag, GL Bakris
The American journal of medicine 121 (4), 332-340, 2008
Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications
PA Sarafidis, LM Ruilope
American journal of nephrology 26 (3), 232-244, 2006
The metabolic syndrome: a glance at its history
PA Sarafidis, PM Nilsson
Journal of hypertension 24 (4), 621-626, 2006
Protection of the kidney by thiazolidinediones: an assessment from bench to bedside
PA Sarafidis, GL Bakris
Kidney international 70 (7), 1223-1233, 2006
Antihypertensive therapy in the presence of proteinuria
PA Sarafidis, N Khosla, GL Bakris
American Journal of Kidney Diseases 49 (1), 12-26, 2007
Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis
PA Sarafidis, PC Stafylas, PI Georgianos, AN Saratzis, AN Lasaridis
American Journal of Kidney Diseases 55 (5), 835-847, 2010
Resistant hypertension—its identification and epidemiology
PA Sarafidis, P Georgianos, GL Bakris
Nature Reviews Nephrology 9 (1), 51-58, 2013
The systemic nature of CKD
C Zoccali, R Vanholder, ZA Massy, A Ortiz, P Sarafidis, FW Dekker, ...
Nature Reviews Nephrology 13 (6), 344, 2017
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–Europeaná…
PA Sarafidis, A Persu, R Agarwal, M Burnier, P De Leeuw, CJ Ferro, ...
Nephrology Dialysis Transplantation 32 (4), 620-640, 2017
Insulin and endothelin: an interplay contributing to hypertension development?
PA Sarafidis, GL Bakris
The Journal of Clinical Endocrinology & Metabolism 92 (2), 379-385, 2007
Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic
PA Sarafidis, R Blacklock, E Wood, A Rumjon, S Simmonds, ...
Clinical Journal of the American Society of Nephrology 7 (8), 1234-1241, 2012
Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease
PA Sarafidis, GL Bakris
Nephrology Dialysis Transplantation 21 (9), 2366-2374, 2006
Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia
AI Kanaki, PA Sarafidis, PI Georgianos, K Kanavos, IM Tziolas, ...
American journal of hypertension 26 (5), 608-616, 2013
Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease
I Karamouzis, PA Sarafidis, M Karamouzis, S Iliadis, AB Haidich, A Sioulis, ...
American journal of nephrology 28 (3), 397-404, 2008
Carvedilol in hypertension treatment
PC Stafylas, PA Sarafidis
Vascular health and risk management 4 (1), 23, 2008
State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension
PA Sarafidis, GL Bakris
The Journal of Clinical Hypertension 10 (2), 130-139, 2008
Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes
PA Sarafidis, AN Lasaridis, PM Nilsson, MI Pikilidou, PC Stafilas, ...
Journal of human hypertension 21 (9), 709-716, 2007
The system can't perform the operation now. Try again later.
Articles 1–20